Activation of natural killer cells by rituximab in granulomatosis with polyangiitis
Doris Urlaub, Wolfgang Merkt(Düsseldorf University Hospital), Theresa Tretter(Heidelberg University), Shuyang Zhao(Perinatal Institute), Norbert Blank, Hanns‐Martin Lorenz, Maren Claus(TU Dortmund University), Raoul Bergner(Klinikum Ludwigshafen), Carsten Watzl(TU Dortmund University)
Cited by 18
Related Papers
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement
|Lara D. Veeken|2008|287
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
|Arthritis Research & Therapy|2011|212
Guided construction of single cell reference for human and mouse lung
|Nature Communications|2023|175
Faecalibacterium prausnitzii: A Next-Generation Probiotic in Gut Disease Improvement
|Canadian Journal of Infectious Diseases and Medical Microbiology|2021|118